Randomised Evaluation News Today

Empagliflozin did not improve rates of mortality, hospital discharge, or mechanical ventilation among patients hospitalized with COVID-19.

Empagliflozin did not improve rates of mortality, hospital discharge, or mechanical ventilation among patients hospitalized with COVID-19.

A trial has been launched in the UK to find effective treatments for flu.

Medical terminology and slang contain many abbreviations, of which acronyms and backronyms are varieties. There are many acronymic forms according to pronunciation and formation. Regarding pronunciation, there are acronyms that form real words; acronyms that resemble incorrectly spelt real words; and acronyms that can be pronounced as if they were real words but aren’t. Regarding formation, some acronyms are formed solely from the first letters of the words they represent; acronyms that use mo...

Here MailOnline lays bare seven decades of NHS history marking how its changed alongside medical advancements, and highlighting key events with archive photography.

-- Winners represent excellence in scientific innovation in pharmaceuticals, biotechnology, medical technology, digital health, and the public sector LONDON, May 12, 2023 /PRNewswire/ --

-- Winners to be Announced and Recognised on 11 May at the Prix Galien UK Awards Ceremony in London LONDON, May 2, 2023 /PRNewswire/ -- The Galien Foundation, the premier global institution

In patients hospitalised for COVID-19 with clinical hypoxia who required either no oxygen or simple oxygen only, higher dose corticosteroids significantly increased the risk of death compared with usual care, which included low-dose corticosteroids. The RECOVERY trial continues to assess the effects of higher dose corticosteroids in patients hospitalised with COVID-19 who require non-invasive ventilation, invasive mechanical ventilation, or extracorporeal membrane oxygenation.

We’re used to randomised trials in medicine. Why not apply the same rigour to policy?

Rafael Dal-Ré and Arthur L Caplan state that obtaining consent “was clearly not an issue in RECOVERY [the Randomised Evaluation of COVID-19 Therapy trial]” and use this statement to support their supposition that there is “no need” to reconsider regulations for written informed consent obtained prospectively from acutely ill patients. However, in the RECOVERY trial,1 if no family member was available, patients who lacked capacity to consent could be enrolled without providing informed c...